Free Trial
→ Man who predicted $100K Bitcoin sees a huge run coming for another coin … (From Weiss Ratings) (Ad) Buy ASPI Stock  Free ASPI Stock Alerts

ASP Isotopes (ASPI) Financials

ASP Isotopes logo
$7.98 -0.61 (-7.10%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$8.00 +0.01 (+0.19%)
As of 07:39 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for ASP Isotopes

Annual Income Statements for ASP Isotopes

This table shows ASP Isotopes' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Income / (Loss) Attributable to Common Shareholders		 -35 -16 -4.95
Consolidated Net Income / (Loss)		 -32 -16 -4.95
Net Income / (Loss) Continuing Operations		 -32 -16 -4.95
Total Pre-Tax Income 		-32 -16 -4.95
Total Operating Income		 -26 -16 -5.10
Total Gross Profit		 1.60 0.14 0.00
Total Revenue		 4.14 0.43 0.00
Operating Revenue		 4.14 0.43 0.00
Total Cost of Revenue		 2.54 0.29 0.00
Operating Cost of Revenue		 2.54 0.29 0.00
Total Operating Expenses		 28 16 5.10
Selling, General & Admin Expense		 25 15 3.83
Research & Development Expense		 3.14 0.76 1.27
Total Other Income / (Expense), net		 -5.96 -0.26 0.15
Interest Expense		 0.26 0.12 0.00
Interest & Investment Income		 1.24 0.01 0.00
Other Income / (Expense), net		 -6.94 -0.15 0.15
Income Tax Expense		 0.11 -0.01 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest		 -0.09 -0.01 0.00
Basic Earnings per Share		 ($0.63) ($0.49) -
Weighted Average Basic Shares Outstanding		 55.67M 33.07M 26.79M
Diluted Earnings per Share		 ($0.63) ($0.49) -
Weighted Average Diluted Shares Outstanding		 55.67M 33.07M 26.79M
Weighted Average Basic & Diluted Shares Outstanding		 72.07M 33.07M 26.79M

Quarterly Income Statements for ASP Isotopes

This table shows ASP Isotopes' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 -9.18 -7.27 -12 -6.95 -4.16 -4.22 -4.29 -3.62 - -1.81
Consolidated Net Income / (Loss)		 -9.22 -7.36 -8.88 -6.96 -4.17 -4.22 -4.29 -3.62 - -3.91
Net Income / (Loss) Continuing Operations		 -9.13 -7.36 -8.88 -7.06 -4.17 -4.22 -4.29 -3.62 - -3.91
Total Pre-Tax Income 		-9.07 -7.36 -8.87 -7.01 -4.18 -4.22 -4.29 -3.62 - -3.91
Total Operating Income		 -7.65 -5.43 -7.46 -5.81 -4.02 -3.95 -4.35 -3.72 - -1.95
Total Gross Profit		 0.61 0.29 0.42 0.28 0.14 0.00 0.00 0.00 - 0.00
Total Revenue		 1.19 1.09 1.02 0.84 0.43 0.00 0.00 0.00 - 0.00
Operating Revenue		 1.19 1.09 1.02 0.84 0.43 0.00 0.00 0.00 - -
Total Cost of Revenue		 0.59 0.79 0.60 0.56 0.29 0.00 0.00 0.00 - 0.00
Operating Cost of Revenue		 0.59 0.79 0.60 0.56 0.29 0.00 0.00 0.00 - -
Total Operating Expenses		 8.25 5.73 7.88 6.09 4.16 3.95 4.35 3.72 - 3.91
Selling, General & Admin Expense		 6.84 4.69 7.41 5.88 4.10 3.71 4.09 3.52 - 1.21
Research & Development Expense		 1.42 1.03 0.47 0.22 0.07 0.24 0.25 0.21 - 0.75
Total Other Income / (Expense), net		 -1.42 -1.93 -1.41 -1.20 -0.15 -0.28 0.06 0.11 - -0.00
Interest Expense		 0.09 0.09 0.07 0.01 0.12 0.00 0.00 0.00 - -
Interest & Investment Income		 0.58 0.60 0.04 0.01 0.00 0.00 0.00 0.00 - 0.00
Other Income / (Expense), net		 -1.92 -2.44 -1.38 -1.20 -0.04 -0.28 0.06 0.11 - -0.00
Income Tax Expense		 0.06 -0.01 0.01 0.05 -0.01 0.00 0.00 0.00 - -
Net Income / (Loss) Attributable to Noncontrolling Interest		 -0.04 -0.08 0.05 -0.02 -0.01 0.00 0.00 0.00 - -
Weighted Average Basic Shares Outstanding		 55.67M 61.53M 66.69M 51.76M 33.07M 31.15M 29.80M 29.14M 26.79M 30.11M
Weighted Average Diluted Shares Outstanding		 55.67M 61.53M 66.69M 51.76M 33.07M 31.15M 29.80M 29.14M 26.79M -
Weighted Average Basic & Diluted Shares Outstanding		 72.07M 71.39M 49.14M 44.56M 33.07M 31.15M 29.80M 29.14M 26.79M -

Annual Cash Flow Statements for ASP Isotopes

This table details how cash moves in and out of ASP Isotopes' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Change in Cash & Equivalents		 54 5.52 -0.77
Net Cash From Operating Activities		 -17 -5.41 -2.94
Net Cash From Continuing Operating Activities		 -17 -5.41 -2.94
Net Income / (Loss) Continuing Operations		 -32 -16 -4.95
Consolidated Net Income / (Loss)		 -32 -16 -4.95
Depreciation Expense		 0.47 0.04 0.00
Non-Cash Adjustments To Reconcile Net Income		 18 9.58 1.93
Changes in Operating Assets and Liabilities, net		 -2.34 1.26 0.07
Net Cash From Investing Activities		 -11 -2.45 -4.47
Net Cash From Continuing Investing Activities		 -11 -2.45 -4.47
Purchase of Property, Plant & Equipment		 -9.68 -2.33 -4.47
Acquisitions		 0.00 -0.12 0.00
Other Investing Activities, net		 -1.70 0.00 -
Net Cash From Financing Activities		 83 13 6.64
Net Cash From Continuing Financing Activities		 83 13 6.64
Repayment of Debt		 -0.61 -0.70 0.00
Repurchase of Common Equity		 -3.65 -0.56 -1.47
Issuance of Debt		 26 0.53 0.00
Issuance of Common Equity		 53 14 8.12
Other Financing Activities, net		 7.27 -0.01 -0.01

Quarterly Cash Flow Statements for ASP Isotopes

This table details how cash moves in and out of ASP Isotopes' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 11 23 6.53 14 5.57 -0.47 -1.71 2.13 0.82 -
Net Cash From Operating Activities		 -3.76 -4.84 -5.12 -2.97 -2.06 -0.65 -1.26 -1.44 -0.86 -
Net Cash From Continuing Operating Activities		 -3.76 -7.30 -0.60 -5.03 -2.06 0.17 -1.51 -2.01 -1.80 -
Net Income / (Loss) Continuing Operations		 -9.22 -7.36 -8.88 -6.96 -4.17 -4.22 -4.29 -3.62 -1.30 -
Consolidated Net Income / (Loss)		 -9.22 -7.36 -8.88 -6.96 -4.17 -4.22 -4.29 -3.62 -1.30 -
Depreciation Expense		 0.05 0.18 0.15 0.10 0.04 0.00 0.00 0.00 - -
Non-Cash Adjustments To Reconcile Net Income		 4.65 5.91 5.88 1.15 2.16 2.90 2.37 2.14 0.99 -
Changes in Operating Assets and Liabilities, net		 0.76 -6.04 2.36 0.58 -0.09 1.52 0.38 -0.55 -1.43 -
Net Cash From Investing Activities		 -3.02 -4.48 -2.62 -1.25 -1.26 -0.68 -0.15 -0.36 -0.90 -
Net Cash From Continuing Investing Activities		 -3.02 -4.48 -2.62 -1.25 -1.26 -0.68 -0.15 -0.36 -0.90 -
Purchase of Property, Plant & Equipment		 -1.32 -4.48 -2.62 -1.25 -1.14 -0.68 -0.15 -0.36 -0.90 -
Net Cash From Financing Activities		 18 32 12 20 8.89 - - 4.49 3.79 -
Net Cash From Continuing Financing Activities		 18 32 12 20 8.89 - - 4.49 3.79 -
Repayment of Debt		 -0.17 - -0.18 -0.26 -0.70 - - 0.00 0.01 -
Repurchase of Common Equity		 -1.45 -2.19 - - -0.06 - - - -1.21 -
Issuance of Debt		 0.50 - 5.39 21 0.53 - - 0.00 - -
Issuance of Common Equity		 19 29 5.54 0.00 9.13 - - 5.00 5.00 -
Other Financing Activities, net		 0.23 5.57 1.48 -0.01 -0.01 - 0.51 -0.51 - -

Annual Balance Sheets for ASP Isotopes

This table presents ASP Isotopes' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Total Assets		 94 28 12
Total Current Assets		 66 11 3.30
Cash & Equivalents		 62 7.91 2.39
Accounts Receivable		 0.71 0.22 0.00
Inventories, net		 0.07 0.00 -
Prepaid Expenses		 3.05 1.66 0.91
Other Current Assets		 0.03 0.72 0.00
Plant, Property, & Equipment, net		 22 11 8.20
Total Noncurrent Assets		 6.25 6.32 0.99
Goodwill		 3.17 3.27 0.00
Noncurrent Deferred & Refundable Income Taxes		 0.03 0.00 -
Other Noncurrent Operating Assets		 3.05 3.05 0.99
Total Liabilities & Shareholders' Equity		 94 28 12
Total Liabilities		 43 8.71 2.68
Total Current Liabilities		 7.06 5.67 1.94
Short-Term Debt		 0.94 0.47 0.03
Accounts Payable		 1.02 1.11 1.35
Accrued Expenses		 2.28 1.31 0.36
Current Deferred Revenue		 0.88 0.88 0.00
Other Current Liabilities		 1.94 1.90 0.19
Total Noncurrent Liabilities		 36 3.04 0.74
Long-Term Debt		 33 0.00 -
Noncurrent Deferred & Payable Income Tax Liabilities		 0.00 0.11 0.00
Other Noncurrent Operating Liabilities		 2.69 2.93 0.74
Commitments & Contingencies		 0.00 0.00 -
Total Equity & Noncontrolling Interests		 51 19 9.82
Total Preferred & Common Equity		 48 16 9.82
Preferred Stock		 0.00 0.00 0.00
Total Common Equity		 48 16 9.82
Common Stock		 106 41 17
Retained Earnings		 -56 -24 -7.55
Accumulated Other Comprehensive Income / (Loss)		 -2.16 -0.92 0.26
Noncontrolling Interest		 3.27 2.53 0.00

Quarterly Balance Sheets for ASP Isotopes

This table presents ASP Isotopes' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023
Period end date 9/30/2024 6/30/2024 3/31/2024 9/30/2023
Total Assets		 84 55 45 12
Total Current Assets		 56 32 26 2.73
Cash & Equivalents		 52 28 24 2.29
Accounts Receivable		 0.56 0.52 0.35 -
Inventories, net		 0.08 - - -
Prepaid Expenses		 3.87 3.25 1.93 0.44
Other Current Assets		 0.00 0.05 0.00 -
Plant, Property, & Equipment, net		 23 18 14 8.35
Total Noncurrent Assets		 5.05 4.91 4.85 0.80
Goodwill		 3.46 3.29 3.17 -
Other Noncurrent Operating Assets		 1.59 1.63 1.68 0.80
Total Liabilities & Shareholders' Equity		 84 55 45 12
Total Liabilities		 42 40 32 3.23
Total Current Liabilities		 7.43 8.01 7.33 2.60
Short-Term Debt		 0.03 0.03 0.21 0.03
Accounts Payable		 1.80 2.43 2.22 0.40
Accrued Expenses		 1.76 2.46 1.77 1.09
Current Deferred Revenue		 0.88 0.88 0.88 0.88
Other Current Liabilities		 2.95 2.21 2.25 0.19
Total Noncurrent Liabilities		 35 32 25 0.63
Long-Term Debt		 32 29 22 -
Noncurrent Deferred & Payable Income Tax Liabilities		 0.08 0.07 0.06 -
Other Noncurrent Operating Liabilities		 2.83 3.23 2.95 0.63
Commitments & Contingencies		 0.00 - - -
Total Equity & Noncontrolling Interests		 42 14 13 8.64
Total Preferred & Common Equity		 39 11 11 8.64
Preferred Stock		 0.00 0.00 0.00 0.00
Total Common Equity		 39 11 11 8.64
Common Stock		 85 51 43 30
Retained Earnings		 -47 -40 -31 -20
Accumulated Other Comprehensive Income / (Loss)		 0.60 -0.70 -1.46 -1.29
Noncontrolling Interest		 3.32 3.35 2.51 -

Annual Metrics And Ratios for ASP Isotopes

This table displays calculated financial ratios and metrics derived from ASP Isotopes' official financial filings.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Growth Metrics		 - - -
Revenue Growth		 857.04% 0.00% 0.00%
EBITDA Growth		 -103.18% -226.43% 0.00%
EBIT Growth		 -105.62% -227.18% 0.00%
NOPAT Growth		 -64.28% -214.61% 0.00%
Net Income Growth		 -98.98% -229.50% 0.00%
EPS Growth		 -28.57% 0.00% 0.00%
Operating Cash Flow Growth		 -208.47% -84.10% 0.00%
Free Cash Flow Firm Growth		 -102.53% 0.00% 0.00%
Invested Capital Growth		 107.57% 52.67% 0.00%
Revenue Q/Q Growth		 22.49% 0.00% 0.00%
EBITDA Q/Q Growth		 -20.10% -1,667,112.69% 0.00%
EBIT Q/Q Growth		 -19.80% 0.00% 0.00%
NOPAT Q/Q Growth		 -15.95% 0.00% 0.00%
Net Income Q/Q Growth		 -18.45% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 -11.36% -28.34% 0.00%
Free Cash Flow Firm Q/Q Growth		 3.38% 0.00% 0.00%
Invested Capital Q/Q Growth		 6.28% 78.39% 0.00%
Profitability Metrics		 - - -
Gross Margin		 38.60% 32.09% 0.00%
EBITDA Margin		 -791.94% -3,730.34% 0.00%
Operating Margin		 -635.91% -3,704.63% 0.00%
EBIT Margin		 -803.31% -3,738.99% 0.00%
Profit (Net Income) Margin		 -782.36% -3,762.85% 0.00%
Tax Burden Percent		 100.34% 99.96% 100.00%
Interest Burden Percent		 97.06% 100.68% 99.93%
Effective Tax Rate		 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -105.29% -119.11% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -25.33% -15.68% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 12.65% 5.36% 0.00%
Return on Equity (ROE)		 -92.64% -113.75% -100.74%
Cash Return on Invested Capital (CROIC)		 -175.24% -160.81% 0.00%
Operating Return on Assets (OROA)		 -54.62% -80.88% 0.00%
Return on Assets (ROA)		 -53.20% -81.39% 0.00%
Return on Common Equity (ROCE)		 -84.96% -103.69% -100.74%
Return on Equity Simple (ROE_SIMPLE)		 -67.69% -99.99% -50.37%
Net Operating Profit after Tax (NOPAT)		 -18 -11 -3.57
NOPAT Margin		 -445.14% -2,593.24% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -79.96% -103.43% -58.41%
Return On Investment Capital (ROIC_SIMPLE)		 -21.57% -58.18% -
Cost of Revenue to Revenue		 61.40% 67.91% 0.00%
SG&A Expenses to Revenue		 598.77% 3,560.15% 0.00%
R&D to Revenue		 75.74% 176.57% 0.00%
Operating Expenses to Revenue		 674.51% 3,736.72% 0.00%
Earnings before Interest and Taxes (EBIT)		 -33 -16 -4.95
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -33 -16 -4.95
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 6.75 5.36 0.00
Price to Tangible Book Value (P/TBV)		 7.23 6.70 0.00
Price to Revenue (P/Rev)		 78.04 201.61 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 12.65 7.23 0.00
Enterprise Value to Revenue (EV/Rev)		 72.18 190.29 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 0.67 0.03 0.00
Long-Term Debt to Equity		 0.65 0.00 0.00
Financial Leverage		 -0.50 -0.34 -0.24
Leverage Ratio		 1.74 1.40 1.27
Compound Leverage Factor		 1.69 1.41 1.27
Debt to Total Capital		 40.18% 2.44% 0.34%
Short-Term Debt to Total Capital		 1.10% 2.44% 0.34%
Long-Term Debt to Total Capital		 39.09% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 3.82% 13.13% 0.00%
Common Equity to Total Capital		 56.00% 84.43% 99.66%
Debt to EBITDA		 -1.05 -0.03 -0.01
Net Debt to EBITDA		 0.84 0.46 0.48
Long-Term Debt to EBITDA		 -1.02 0.00 0.00
Debt to NOPAT		 -1.86 -0.04 -0.01
Net Debt to NOPAT		 1.49 0.66 0.66
Long-Term Debt to NOPAT		 -1.81 0.00 0.00
Altman Z-Score		 3.29 3.09 0.00
Noncontrolling Interest Sharing Ratio		 8.29% 8.85% 0.00%
Liquidity Ratios		 - - -
Current Ratio		 9.31 1.85 1.71
Quick Ratio		 8.87 1.43 1.23
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 -31 -15 0.00
Operating Cash Flow to CapEx		 -172.56% -232.16% -65.72%
Free Cash Flow to Firm to Interest Expense		 -118.61 -127.88 0.00
Operating Cash Flow to Interest Expense		 -64.49 -45.66 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -101.87 -65.32 0.00
Efficiency Ratios		 - - -
Asset Turnover		 0.07 0.02 0.00
Accounts Receivable Turnover		 8.98 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00
Fixed Asset Turnover		 0.25 0.05 0.00
Accounts Payable Turnover		 2.39 0.24 0.00
Days Sales Outstanding (DSO)		 40.67 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 152.99 1,530.92 0.00
Cash Conversion Cycle (CCC)		 -112.33 -1,530.92 0.00
Capital & Investment Metrics		 - - -
Invested Capital		 24 11 7.46
Invested Capital Turnover		 0.24 0.05 0.00
Increase / (Decrease) in Invested Capital		 12 3.93 0.00
Enterprise Value (EV)		 299 82 0.00
Market Capitalization		 323 87 0.00
Book Value per Share		 $0.67 $0.33 $0.37
Tangible Book Value per Share		 $0.63 $0.27 $0.37
Total Capital		 86 19 9.85
Total Debt		 34 0.47 0.03
Total Long-Term Debt		 33 0.00 0.00
Net Debt		 -28 -7.44 -2.36
Capital Expenditures (CapEx)		 9.68 2.33 4.47
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -2.27 -2.60 -0.99
Debt-free Net Working Capital (DFNWC)		 60 5.31 1.40
Net Working Capital (NWC)		 59 4.84 1.37
Net Nonoperating Expense (NNE)		 14 5.06 1.38
Net Nonoperating Obligations (NNO)		 -28 -7.44 -2.36
Total Depreciation and Amortization (D&A)		 0.47 0.04 0.00
Debt-free, Cash-free Net Working Capital to Revenue		 -54.67% -600.77% 0.00%
Debt-free Net Working Capital to Revenue		 1,438.74% 1,225.49% 0.00%
Net Working Capital to Revenue		 1,416.08% 1,116.86% 0.00%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 ($0.63) $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 55.67M 33.07M 0.00
Adjusted Diluted Earnings per Share		 ($0.63) $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 55.67M 33.07M 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 72.07M 33.07M 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 -18 -11 -3.57
Normalized NOPAT Margin		 -445.14% -2,593.24% 0.00%
Pre Tax Income Margin		 -779.67% -3,764.27% 0.00%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 -128.60 -136.58 0.00
NOPAT to Interest Expense		 -71.26 -94.73 0.00
EBIT Less CapEx to Interest Expense		 -165.98 -156.24 0.00
NOPAT Less CapEx to Interest Expense		 -108.64 -114.39 0.00
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -11.25% -3.46% -29.63%

Quarterly Metrics And Ratios for ASP Isotopes

This table displays calculated financial ratios and metrics derived from ASP Isotopes' official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 175.71% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 -136.43% -82.22% -103.56% -89.22% 0.00% -115.98% 0.00% 0.00% 0.00% 0.00%
EBIT Growth		 -135.43% -86.35% -106.23% -93.91% 0.00% -116.02% 0.00% 0.00% 0.00% 0.00%
NOPAT Growth		 -90.10% -37.68% -71.53% -56.11% 0.00% -101.99% 0.00% 0.00% 0.00% 0.00%
Net Income Growth		 -121.12% -74.20% -107.20% -92.66% 0.00% -7.92% 0.00% 0.00% 0.00% 0.00%
EPS Growth		 0.00% 14.29% 0.00% 0.00% 0.00% -133.33% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 -82.76% -640.92% -307.72% -105.57% -138.65% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Growth		 -161.00% -114.98% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth		 107.57% 248.42% 0.00% 0.00% 52.67% 0.00% 0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth		 9.76% 6.40% 21.65% 94.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 -23.62% 11.46% -27.71% -69.15% 4.73% 1.09% -18.71% 0.00% 100.00% 0.00%
EBIT Q/Q Growth		 -21.44% 10.94% -26.12% -72.60% 3.88% 1.43% -18.59% 0.00% 100.00% 0.00%
NOPAT Q/Q Growth		 -40.75% 27.14% -28.25% -44.53% -1.94% 9.22% -16.72% 0.00% 100.00% 0.00%
Net Income Q/Q Growth		 -25.36% 17.18% -27.52% -13,426.27% 1.24% 1.49% -18.57% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 22.32% 5.55% -72.52% -44.39% -214.91% 48.03% 13.01% -67.62% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 10.47% 3.76% -32.45% -128.71% 26.26% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 6.28% 46.23% 33.96% -0.29% 78.39% 0.00% 0.00% -100.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 50.74% 27.03% 41.18% 33.18% 32.09% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 -797.18% -707.83% -850.59% -810.25% -929.61% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 -640.58% -499.55% -729.48% -691.95% -929.07% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 -801.01% -724.01% -864.93% -834.28% -938.03% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 -772.36% -676.24% -868.77% -828.80% -963.04% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 101.69% 99.89% 100.16% 99.32% 99.85% 100.00% 100.00% 100.00% 0.00% 100.07%
Interest Burden Percent		 94.82% 93.51% 100.29% 100.02% 102.82% 99.92% 99.97% 99.99% 0.00% 199.85%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -106.06% -82.62% -154.06% -108.59% -29.87% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -83.93% -50.35% -1,009.54% 238.73% -2.22% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 41.92% 21.88% -60.17% -30.54% 0.76% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -64.15% -60.74% -214.23% -139.13% -29.11% 0.00% 0.00% 0.00% -100.74% 0.00%
Cash Return on Invested Capital (CROIC)		 -175.24% -221.91% -395.42% -423.45% -160.81% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -54.47% -51.03% -72.52% -46.81% -20.29% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 -52.52% -47.67% -72.84% -46.51% -20.83% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 -58.83% -56.76% -164.26% -112.33% -26.54% 0.00% 0.00% 0.00% -100.74% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -70.74% -220.12% -186.77% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -5.35 -3.80 -5.22 -4.07 -2.82 -2.76 -3.04 -2.61 0.00 -1.37
NOPAT Margin		 -448.41% -349.69% -510.64% -484.36% -650.35% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -22.13% -32.27% 855.48% -347.31% -27.65% -129.60% 0.00% 0.00% 0.00% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 -6.26% - - - -14.59% - - - - -
Cost of Revenue to Revenue		 49.26% 72.97% 58.82% 66.82% 67.91% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 572.71% 431.48% 724.37% 699.53% 946.11% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 118.61% 95.10% 46.30% 25.60% 15.05% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 691.32% 526.58% 770.66% 725.13% 961.16% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -9.56 -7.87 -8.84 -7.01 -4.06 -4.23 -4.29 -3.62 0.00 -1.96
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -9.52 -7.70 -8.70 -6.81 -4.03 -4.23 -4.27 -3.60 0.00 -1.96
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 6.75 4.79 14.38 19.15 5.36 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 7.23 5.26 20.51 27.40 6.70 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 78.04 54.79 69.00 158.19 201.61 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 12.65 7.59 10.69 17.81 7.23 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 72.18 49.93 70.83 158.85 190.29 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.67 0.76 2.03 1.71 0.03 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.65 0.76 2.03 1.69 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.50 -0.43 0.06 -0.13 -0.34 -0.26 0.00 0.00 -0.24 0.00
Leverage Ratio		 1.74 1.90 3.81 3.48 1.40 1.37 0.00 0.00 1.27 0.00
Compound Leverage Factor		 1.65 1.77 3.82 3.48 1.44 1.37 0.00 0.00 0.00 0.00
Debt to Total Capital		 40.18% 43.09% 66.97% 63.05% 2.44% 0.39% 0.00% 0.00% 0.34% 0.00%
Short-Term Debt to Total Capital		 1.10% 0.05% 0.07% 0.59% 2.44% 0.39% 0.00% 0.00% 0.34% 0.00%
Long-Term Debt to Total Capital		 39.09% 43.05% 66.90% 62.46% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 3.82% 4.49% 7.71% 7.12% 13.13% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 56.00% 52.42% 25.33% 29.84% 84.43% 99.61% 0.00% 0.00% 99.66% 0.00%
Debt to EBITDA		 -1.05 -1.16 -1.22 -1.14 -0.03 34.94 0.00 0.00 -0.01 0.00
Net Debt to EBITDA		 0.84 0.72 -0.04 0.09 0.46 -2,325.03 0.00 0.00 0.48 0.00
Long-Term Debt to EBITDA		 -1.02 -1.16 -1.22 -1.13 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 -1.86 -2.00 -1.96 -1.75 -0.04 0.00 0.00 0.00 -0.01 0.00
Net Debt to NOPAT		 1.49 1.24 -0.06 0.13 0.66 0.00 0.00 0.00 0.66 0.00
Long-Term Debt to NOPAT		 -1.81 -2.00 -1.96 -1.73 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 4.12 2.28 1.37 2.80 4.54 0.00 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 8.29% 6.55% 23.33% 19.26% 8.85% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 9.31 7.55 4.00 3.57 1.85 1.05 0.00 0.00 1.71 0.00
Quick Ratio		 8.87 7.02 3.59 3.31 1.43 0.88 0.00 0.00 1.23 0.00
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -18 -20 -20 -15 -6.75 -9.15 0.00 0.00 0.00 0.00
Operating Cash Flow to CapEx		 -284.25% -107.93% -195.45% -238.43% -180.27% -95.85% -857.67% -399.10% -95.51% 0.00%
Free Cash Flow to Firm to Interest Expense		 -207.08 -216.23 -295.87 -1,119.13 -56.91 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 -44.21 -53.21 -74.19 -215.44 -17.35 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -59.77 -102.51 -112.15 -305.79 -26.98 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.07 0.07 0.08 0.06 0.02 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 8.98 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.25 0.22 0.00 0.00 0.05 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 2.39 2.05 0.00 0.00 0.24 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 40.67 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 152.99 178.36 0.00 0.00 1,530.92 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 -112.33 -178.36 0.00 0.00 -1,530.92 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 24 22 15 11 11 6.39 0.00 0.00 7.46 0.00
Invested Capital Turnover		 0.24 0.24 0.30 0.22 0.05 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 12 16 15 11 3.93 6.39 0.00 0.00 0.00 0.00
Enterprise Value (EV)		 299 169 163 202 82 0.00 0.00 0.00 0.00 5.00
Market Capitalization		 323 185 158 201 87 0.00 0.00 0.00 0.00 5.00
Book Value per Share		 $0.67 $0.58 $0.21 $0.22 $0.33 $0.28 $0.00 $0.00 $0.37 $0.00
Tangible Book Value per Share		 $0.63 $0.53 $0.15 $0.15 $0.27 $0.28 $0.00 $0.00 $0.37 $0.00
Total Capital		 86 74 43 35 19 8.67 0.00 0.00 9.85 0.00
Total Debt		 34 32 29 22 0.47 0.03 0.00 0.00 0.03 0.00
Total Long-Term Debt		 33 32 29 22 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -28 -20 0.86 -1.67 -7.44 -2.25 0.00 0.00 -2.36 0.00
Capital Expenditures (CapEx)		 1.32 4.48 2.62 1.25 1.14 0.68 0.15 0.36 0.90 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -2.27 -2.87 -4.17 -4.84 -2.60 -2.13 0.00 0.00 -0.99 0.00
Debt-free Net Working Capital (DFNWC)		 60 49 24 19 5.31 0.16 0.00 0.00 1.40 0.00
Net Working Capital (NWC)		 59 49 24 19 4.84 0.13 0.00 0.00 1.37 0.00
Net Nonoperating Expense (NNE)		 3.87 3.55 3.66 2.89 1.35 1.46 1.24 1.01 0.00 2.54
Net Nonoperating Obligations (NNO)		 -28 -20 0.86 -1.67 -7.44 -2.25 0.00 0.00 -2.36 0.00
Total Depreciation and Amortization (D&A)		 0.05 0.18 0.15 0.20 0.04 0.00 0.02 0.02 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue		 -54.67% -84.97% -181.67% -380.09% -600.77% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 1,438.74% 1,439.29% 1,049.44% 1,496.08% 1,225.49% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 1,416.08% 1,438.31% 1,048.06% 1,479.86% 1,116.86% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.12) $0.00 $0.00 $0.00 ($0.14) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 55.67M 61.53M 66.69M 51.76M 33.07M 48.77M 0.00 0.00 26.79M 0.00
Adjusted Diluted Earnings per Share		 $0.00 ($0.12) $0.00 $0.00 $0.00 ($0.14) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 55.67M 61.53M 66.69M 51.76M 33.07M 48.77M 0.00 0.00 26.79M 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 ($0.14) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 72.07M 71.39M 49.14M 44.56M 33.07M 31.15M 0.00 0.00 26.79M 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 -5.35 -3.80 -5.22 -4.07 -2.82 -2.76 -3.04 -2.61 0.00 -1.37
Normalized NOPAT Margin		 -448.41% -349.69% -510.64% -484.36% -650.35% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 -759.49% -677.01% -867.42% -834.47% -964.46% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 -112.46 -86.57 -128.00 -508.48 -34.26 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 -62.96 -41.81 -75.57 -295.21 -23.76 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -128.02 -135.87 -165.96 -598.83 -43.89 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -78.51 -91.11 -113.53 -385.57 -33.38 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -11.25% -8.22% -0.24% 0.00% -3.46% 0.00% 0.00% 0.00% -29.63% 0.00%

Frequently Asked Questions About ASP Isotopes' Financials

When does ASP Isotopes's fiscal year end?

According to the most recent income statement we have on file, ASP Isotopes' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has ASP Isotopes' net income changed over the last 2 years?

ASP Isotopes' net income appears to be on an upward trend, with a most recent value of -$32.42 million in 2024, rising from -$4.95 million in 2022. The previous period was -$16.29 million in 2023. Check out ASP Isotopes' forecast to explore projected trends and price targets.

What is ASP Isotopes's operating income?
ASP Isotopes's total operating income in 2024 was -$26.35 million, based on the following breakdown:
  • Total Gross Profit: $1.60 million
  • Total Operating Expenses: $27.95 million
How has ASP Isotopes revenue changed over the last 2 years?

Over the last 2 years, ASP Isotopes' total revenue changed from $0.00 in 2022 to $4.14 million in 2024, a change of 414,422,600.0%.

How much debt does ASP Isotopes have?

ASP Isotopes' total liabilities were at $43.18 million at the end of 2024, a 395.7% increase from 2023, and a 1,512.0% increase since 2022.

How much cash does ASP Isotopes have?

In the past 2 years, ASP Isotopes' cash and equivalents has ranged from $2.39 million in 2022 to $61.89 million in 2024, and is currently $61.89 million as of their latest financial filing in 2024.

How has ASP Isotopes' book value per share changed over the last 2 years?

Over the last 2 years, ASP Isotopes' book value per share changed from 0.37 in 2022 to 0.67 in 2024, a change of 83.1%.


Related Companies

This page (NASDAQ:ASPI) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners
Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...
Augusta Precious Metals | Sponsored
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
F1 Engineering Powers This Electric Marine Motor
The future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...
The Tomorrow Investor | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Take a look at this picture ...
A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...
Weiss Ratings | Sponsored
We’ve Entered the Most Bullish Phase of the Cycle
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...
Crypto Swap Profits | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored